Emergency Use Transparency Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Emergency Use Transparency Act
This bill expands existing statutory provisions requiring the Food and Drug Administration (FDA) to publish notices of authorizations, terminations, or revocations of emergency use authorizations for medical products.
Specifically, the bill requires the FDA to publish such notices on its website. The bill also allows the FDA's disclosures to include a summary of data or information from additional types of submissions.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 3394: Emergency Use Transparency Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-3394/
"S. 3394: Emergency Use Transparency Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-3394/.
S. 3394, 117th Cong. (2026), https://openamerica.io/bill/117-S-3394/.
[S. 3394: Emergency Use Transparency Act](https://openamerica.io/bill/117-S-3394/)